Details

NameSymbolSector
MANGALAM DRUGS AND ORGANICS LTD.MANGALAMPharmaceuticals
Open
29
High
29.9
Low
27.6
Close
28.07
Volume
41613
Exchange
nse
Time
14-Aug-2026

Outlook

Score:

3.5

Rating:

FAIR

Candlestick Pattern

CandlepatternofMangalamDrugsAndOrganicsis
Long Body
EstimatedStoplossofMangalamDrugsAndOrganicsis
29.9
MangalamDrugsAndOrganicshasa
Bearishℹ
pattern.
Formationof
Long Body
candlepatternindicatesthetrenddirectionofMangalamDrugsAndOrganicsmaybe
Unpredictableℹ
,butkeepalookoutforfallinprice.

Trend

MangalamDrugsAndOrganicsisin
Sideways trendℹ
.
PriceofMangalamDrugsAndOrganicsis
Upℹ
by

0.75

%.
Target
Buy@

26.1

Sell@

30.8

Current@

28.07

Volume

ThetradesofMangalamDrugsAndOrganicshavebeenin
Immenseℹ
volume.
ThevolumetradesforMangalamDrugsAndOrganicsare
Bullishℹ
with
Strong Buyersℹ
ThetradevolumeofMangalamDrugsAndOrganicsis

Up

by

60.16

%

Valuation

ThecurrentmarketpriceofMangalamDrugsAndOrganicsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth366crandtotalassetsworth366cr,thebalancesheetofMangalamDrugsAndOrganicsis:
Balancedℹ
.
Cashflow
MangalamDrugsAndOrganicshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 1cr

.Itis
Upℹ
by

150

%.
51.22% i.e. ₹ 42cr earned in operatingℹ
23.17% i.e. ₹ 19cr spent in investingℹ
25.61% i.e. ₹ 21cr spent in financingℹ
0% in otherℹ
MangalamDrugsAndOrganicshas
Insufficientℹ
cashflowbecausethereis

Shortage

of

₹ 2cr

.Itis
Downℹ
by

0

%.
15.79% i.e. ₹ 3cr earned in operatingℹ
57.89% i.e. ₹ 11cr spent in investingℹ
26.32% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
TheincomeofMangalamDrugsAndOrganicsis

₹ 49cr

and

Loss

is:

₹ 7cr

MangalamDrugsAndOrganicsLossesdecreasedby:

46.15

%andIncomeisDownby:

14.04

%
TheincomeofMangalamDrugsAndOrganicsis

₹ 57cr

and

Loss

is:

₹ 13cr

MangalamDrugsAndOrganicsLossesincreasedby:

1300

%andIncomeisDownby:

21.92

%
TheincomeofMangalamDrugsAndOrganicsis

₹ 73cr

and

Loss

is:

₹ 0cr

MangalamDrugsAndOrganicsLossesincreasedby:

100

%andIncomeisDownby:

17.05

%
By using this site you agree to the use of cookies to deliver a better site experience.